Events, By Category and Date:» Go to news main
Challenge Studies for COVID‑19: Now Is Not the Time
Getz L, & Baylis F. (6 Apr 2021). Challenge studies for COVID-19: Now is not the time. Journal of Medical Ethics Blog.
hVIVO, a for-profit clinical research organization in London, in collaboration with Imperial College London, has initiated a human challenge study in youth between the ages of 18 and 30 to determine the dose at which individuals become infected with SARS-CoV-2, the virus that causes COVID-19. The dose-ranging study, which began in March 2021, is the first in a planned series of human challenge trials where healthy volunteers will be intentionally exposed to the novel coronavirus.
While there is some enthusiasm for this study among potential volunteers, there is reason to question the ethics of this research which involves intentionally putting youth in harms way. Read more...
- Permissive regulation: A critical review of the regulatory history of buprenorphine formulations in Canada
- On what basis did Health Canada approve OxyContin in 1996? A retrospective analysis of regulatory data
- Fair pricing of “old” orphan drugs: considerations for Canada’s orphan drug policy
- Matthew Herder Resigns from Patented Medicine Prices Review Board
- Podcast or Perish: Episode 040: Françoise Baylis
- Bioethicist Françoise Baylis asks why humans think 'they can just take everything'
- Killam Prize winners discuss research in Canada
- World‑renowned Dalhousie bioethicist and battery pioneer win prestigious Killam Prize